All companies
Visit website
Love Sun Body
OperatingLove Sun Body LLC
Healthcare · Founded 2012
Innovator of the First 100% Cosmos Natural Sunscreens & Application Technology
Post-money valuation ⓘ
$29.9M
As of Apr 2024 · from LOVE SUN BODY Preferred Stock 3 · pre-money + amount raised, not a traded price
Total raised
$394,933
Across 3 rounds since 2020
Latest share price
$1.15
LOVE SUN BODY Preferred Stock 3 offering price
Financials
FY2018–FY2022 · from SEC filings · hover any figure for its source$70K
−$789K
2018
$166K
−$812K
2019
$135K
−$673K
2020
$70K
−$789K
2021
$166K
−$812K
2022
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2018
FY2019
FY2020
FY2021
FY2022
Income statement
Revenue
$70,145
$165,785
$134,961
$70,145
$165,785
Cost of goods sold
$112,307
$308,165
$54,956
$112,307
$308,165
Gross margin
-60%
-86%
59%
-60%
-86%
Net income
-$789,160
-$811,744
-$673,408
-$789,160
-$811,744
Taxes paid
$0
$0
$0
$0
$0
Balance sheet
Cash
$431,026
$202,736
$94,220
$431,026
$202,736
Accounts receivable
$2,878
$2,155
$0
$2,878
$2,155
Total assets
$608,889
$396,915
$416,397
$608,889
$396,915
Short-term debt
$48,734
$409,970
$452,481
$48,734
$409,970
Long-term debt
$0
$0
$0
$0
$0
Total liabilities
$48,734
$409,970
$452,481
$48,734
$409,970
Other
Headcount
—
5
5
—
10
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$21.6M
post-money
$31.4M
post-money
$29.9M
post-money
Love Sun Body Stock 1
Love Sun Body Common Stock 1
LOVE SUN BODY Preferred Stock 3
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $2.4K / $618KPost-money $29.9M
Raised $140.3K / $2MInvestors 70Post-money $31.4M
Reg CF annual-report compliance
Not requiredFewer than 300 holders of record
Filed 2 of 6 annual reports (FY2020–FY2025)
103 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 12 filings on EDGARSource: ManualCIK 0001820463Share price $1.15
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.